Registered entities
Colucid Pharmaceuticals, Inc.
Reg. No. 1348649United States
Innovation
10 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 762 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Investor mix
10 investors on record; lead investors include Domain Associates, Pappas Capital, Triathlon Medical Ventures, Pearl Street Venture Funds; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 70% |
| Private equity | 2 | 20% |
| Other / undisclosed | 1 | 10% |